Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2020-10-07 | 2020-12-17 | 125815 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
| APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2019-02-24 | 2019-03-29 | 76729 |
| APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2017-11-07 | 2018-01-11 | 28564 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2022-10-28 | 2022-12-09 | 172901 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121337 |
| APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121334 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2023-07-27 | 2023-09-28 | 200180 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2022-10-07 | 2022-12-05 | 171422 |
| APO-OLANZAPINE | 10.0MG | TABLET | Resolved | 2017-08-23 | 2017-10-03 | 20113 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157701 |
| APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2018-02-01 | 2018-05-25 | 37997 |
| APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2019-05-15 | 2019-06-24 | 84128 |
| APO-OLANZAPINE | 15.0MG | TABLET | Resolved | 2017-12-14 | 2018-04-05 | 32818 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-10-17 | 2022-12-05 | 171886 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2023-07-13 | 2023-09-15 | 198518 |
| APO-OLANZAPINE | 5.0MG | TABLET | Resolved | 2020-02-13 | 2020-06-02 | 106006 |
| APO-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-04-13 | 2020-12-21 | 111928 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-07-21 | 2023-11-06 | 199515 |
| APO-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-04-27 | 2023-06-02 | 190862 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO FUROSEMIDE TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO FUROSEMIDE TAB 40MG | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO FUROSEMIDE TAB 80MG | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
| APO HYDRO TAB 100MG | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO HYDRO TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
| APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
| APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO METOPROLOL (TYPE L) TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
| APO METOPROLOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO NAPROXEN TAB 250MG | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
| APO OXAZEPAM TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
| APO OXAZEPAM TAB 15MG | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO OXAZEPAM TAB 30MG | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |